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James D. Chalmers is a Wellcome Trust Postdoctoral Fellow and
Lecturer in Respiratory Medicine at the University of Dundee, UK.
He trained in Glasgow and Edinburgh, performing his PhD studies
at the Medical Research Council (MRC) Centre for Inflammation
Research in Edinburgh investigating the role of innate immunity in
non-cystic fibrosis (CF) bronchiectasis. His research and clinical
interests are in respiratory infections, particularly community-
acquired pneumonia (CAP), bronchiectasis and chronic obstructive
pulmonary disease (COPD). He now leads a research group at the
University of Dundee investigating the mechanisms of pulmonary
bacterial infections, supported by grants from the Wellcome Trust,
MRC, Scottish Government and charities.
James Chalmers has been awarded several prestigious young
investigator awards, including from the European Respiratory
Society (ERS) and British Thoracic Society (BTS). He has
published widely on respiratory infections, with over 60 articles in
peer reviewed journals since 2008. He is a member of the
international advisory board of The Lancet Respiratory Medicine.
He is heavily involved in international respiratory societies, being a
current member of the BTS Science and Research Committee, the
ERS Long-Range Planning Committee and the American Thoracic
Society Microbiology, Tuberculosis and Pulmonary Infections
Program Committee.
Mathias W. Pletz, Professor for Infectious Diseases, is a board-
certified physician for internal medicine, pulmonology and
infectious diseases and the head of the Center for Infectious
Diseases and Infection Control of the University Hospital in Jena,
Germany. He also leads a clinical research group focusing on novel
diagnostic and therapeutic strategies against multidrug-resistant
bacterial pathogens, funded by the German Ministry for Science and
Education.
Mathias Pletz received his PhD in Virology at the University of
Leipzig, Germany. During his thesis he worked as a guest researcher
at the Food and Drug Administration Laboratory of Parasitic
Pathology and Biochemistry in Bethesda, MD, USA. After his
medical training at the University of Leipzig, Baylor College of
Medicine (Houston, TX, USA) and the University of Basel
(Switzerland), he started his residency at the Chest Hospital in
Berlin, Germany. Subsequently, he spent 2 years as a postdoctoral
researcher at Emory University (Atlanta, GA, USA), working with
Keith Klugman’s group on the spread of multi-resistant
pneumococci. In addition he served as a guest researcher at the
Centers for Disease Control and Prevention (CDC) in Atlanta,
exploring the severe acute respiratory syndrome (SARS) epidemics.
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After his return to Germany, he finished his medical training at the
Dept of Respiratory Medicine at the Hannover Medical School.
Mathias Pletz is the deputy director of the German Competence
Network for Community-Acquired Pneumonia (CAPNETZ), a
member of the board of directors of the German-Austrian-Swiss
Paul-Ehrlich-Society for antimicrobial chemotherapy, and scientific
advisor for the German Robert Koch Institute. He has published
more than 100 papers on pneumonia, pneumococcal vaccines,
respiratory infections, antimicrobial resistance and pharmaco-
kinetics of antibiotics in the critically ill. He has also received
numerous scientific awards, e.g. the Honor Award Certificate from
the CDC, the Kass-Award of the Infectious Diseases Society of
America and the Respiratory Infections Awards from the ERS.
Stefano Aliberti is Assistant Professor in Respiratory Medicine at the
University of Milan-Bicocca, Milan, Italy, and consultant at the San
Gerardo Hospital in Monza, Italy. He trained at the Institute of
Respiratory Diseases at the University of Milan, under the
mentorship of Professor Francesco Blasi. During his fellowship, he
received research grants to investigate the epidemiology of non-CF
bronchiectasis and COPD, and he worked as a visiting research
fellow at the Division of Infectious Diseases at the University of
Louisville, KY, USA. He has been an active member of the
Community-Acquired Pneumonia Organization (CAPO)
international study group since 2006, and a member of the
Community-Acquired Pneumonia Inflammatory Study Group
(CAPISG). His research and clinical interests are in both acute
and chronic respiratory infections, including CAP, non-CF
bronchiectasis and atypical mycobacteria. He was awarded the
young researcher award in respiratory infections from the ERS in
2007. During the past 10 years, he has been involved in several
clinical and translational studies on these topics at both national and
international level. Stefano Aliberti has published over 60 articles on
CAP in peer-reviewed journals since 2006. He is associate editor of
Breathe and the European Journal of Internal Medicine. He has been
heavily involved in the ERS, as Secretary of the Respiratory Infection
Group and Secretary of the Assembly of Respiratory Infections.
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